[HTML][HTML] Tuberculosis and COVID-19 in the elderly: factors driving a higher burden of disease

A Allué-Guardia, JB Torrelles, A Sigal - Frontiers in Immunology, 2023 - frontiersin.org
Mycobacterium tuberculosis (M. tb) and SARS-CoV-2 are both infections that can lead to
severe disease in the lower lung. However, these two infections are caused by very different …

[HTML][HTML] HDAC1-3 inhibition increases SARS-CoV-2 replication and productive infection in lung mesothelial and epithelial cells

F Trionfetti, T Alonzi, G Bontempi, M Terri… - Frontiers in Cellular …, 2023 - frontiersin.org
Background Despite the significant progress achieved in understanding the pathology and
clinical management of SARS-CoV-2 infection, still pathogenic and clinical issues need to …

Cell-Mediated Immune Response Against Mycobacterium tuberculosis and Its Potential Therapeutic Impact

H Khanna, S Gupta, Y Sheikh - Journal of Interferon & Cytokine …, 2024 - liebertpub.com
Cell-mediated immune response is critical for Mycobacterium tuberculosis (M. tb) control.
Understanding of pathophysiology and role played by different cell mediators is essential for …

Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming

BD Williams, D Ferede, HFM Abdelaal… - Frontiers in …, 2024 - frontiersin.org
At the beginning of the COVID-19 pandemic those with underlying chronic lung conditions,
including tuberculosis (TB), were hypothesized to be at higher risk of severe COVID-19 …

[HTML][HTML] T Cell Response in Tuberculosis-Infected Patients Vaccinated against COVID-19

LHA Cavalcante-Silva, EG Leite, FS Almeida… - Microorganisms, 2023 - mdpi.com
Many studies have focused on SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) co-
infection consequences. However, after a vaccination plan against COVID-19, the cases of …

Sex disparities of the effect of the COVID-19 pandemic on mortality among patients living with tuberculosis in the United States

H Deng, Y Liu, F Lv, X Li, M Qi, Y Bo, S Qiu… - Frontiers in Public …, 2024 - frontiersin.org
Background We aimed to determine the trend of TB-related deaths during the COVID-19
pandemic. Methods TB-related mortality data of decedents aged≥ 25 years from 2006 to …

[HTML][HTML] Latent tuberculosis infection and COVID-19: analysis of a cohort of patients from Careggi University Hospital (Florence, Italy)

F Mariotti, F Sponchiado, F Lagi, C Moroni… - Infectious Disease …, 2023 - mdpi.com
Data regarding the relationship between coronavirus disease (COVID-19) and active or
latent tuberculosis (TB) are discordant. We conducted a retrospective study examining the …

[HTML][HTML] Interaction between type 2 diabetes and past COVID-19 on active tuberculosis

LE Calles-Cabanillas, GP Aguillón-Durán… - Research …, 2024 - ncbi.nlm.nih.gov
BACKGROUND The global setback in tuberculosis (TB) prevalence and mortality in the post-
COVID-19 era have been partially attributed to pandemic-related disruptions in healthcare …

Study of pyridine derivatives as potential antimycobacterial active drugs.

DE Nawrot - 2024 - dspace.cuni.cz
Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis (Mtb).
Aside from the period of the COVID-19 pandemic, TB stands out as the most significant …

Aspectos biológicos e clínicos da coinfecção tuberculose e COVID-19: uma revisão sistemática

JS de Santana, IO Pinheiro… - … A LAS CIENCIAS …, 2024 - ojs.revistacontribuciones.com
A Covid-19 é uma doença infecciosa altamente contagiosa e potencialmente perigosa que
pode ser assintomática ou sintomática, a depender da resposta imunológica do hospedeiro …